Sublingual lorazepam in the treatment of familial paroxysmal nonkinesigenic dyskinesia

Pediatric Neurology

Volumn 30, Issue 5, 2004, Pages 365-366

  Dooley, Joseph M ^a,b   Brna, Paula M ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; CLONAZEPAM; LORAZEPAM;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DYSKINESIA; FAMILIAL DISEASE; FAMILIAL PAROXYSMAL NONKINESIGENIC DYSKINESIA; FEMALE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT WITHDRAWAL;

ADMINISTRATION, SUBLINGUAL; CHILD; CHOREATIC DISORDERS; FEMALE; HUMANS; LORAZEPAM;

EID: 2542450991     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2003.12.011     Document Type: Article

References (4)

1. Mount L.A., Reback S. Familial paroxysmal choreoathetosis Preliminary report on a hitherto undescribed clinical syndrome. Arch Neurol Psychiatry. 44:1940;841-847
2. Tibbles J.A.R., Barnes S.E. Paroxysmal dystonic choreoathetosis of Mount and Reback. Pediatrics. 65:1980;149-151
3. Hofele K., Benecke R., Auburger G. Gene locus FPD1 of the dystonic Mount-Reback type of autosomal-dominant paroxysmal choreoathetosis. Neurology. 49:1997;1252-1256
4. Demirkiran M., Jankovic J. Paroxysmal dyskinesias Clinical features and classification. Ann Neurol. 38:1995;571-579